APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 263 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $547,014 | -59.9% | 14,260 | -38.5% | 0.08% | -55.5% |
| Q1 2024 | $1,362,638 | +66.0% | 23,182 | +69.1% | 0.17% | +8.1% |
| Q4 2023 | $820,681 | +612.5% | 13,710 | +352.8% | 0.16% | +384.8% |
| Q3 2023 | $115,185 | -46.0% | 3,028 | +29.3% | 0.03% | -50.0% |
| Q2 2023 | $213,265 | +36.7% | 2,341 | -1.1% | 0.07% | +24.5% |
| Q1 2023 | $156,061 | +168.7% | 2,366 | +110.7% | 0.05% | +130.4% |
| Q4 2022 | $58,070 | -17.0% | 1,123 | +9.1% | 0.02% | -20.7% |
| Q3 2022 | $70,000 | – | 1,029 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |